Using IHC, we have demonstrated that 57% (43/74) of MPNSTs have aberrant ATRX expression compared to only 10% (2/21) of plexiform neurofibromas, and no (0/9) atypical neurofibromas, benign precursor lesions to MPNSTs. The gene discussed is ATRX; the disease is neurofibroma.